LONDON: AstraZeneca CEO Pascal Soriot on Wednesday expressed his hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company will be ready by the end of 2020 or early 2021, despite having to pause clinical trials. Earlier this week, the Swedish-British company froze the trials after discovering …
Read More »Oxford Covid 19 Vaccine: AstraZeneca CEO Says Covid-19 Vaccine May Be Ready by Year-End Despite Trial Pause | World News
